Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis

Table 3

Rates of bleeding events in the two groups with different duration of dual antiplatelet therapy.

Study ID	Total number in short duration group	Total number in longer duration group	Thrombolysis in myocardial infarction major bleeding		Gastrointestinal haemorrhage		Intracranial haemorrhage		Total haemorrhage
			Short	Long	Short	Long	Short	Long	Short	Long
Gwon et al. 2012 (EXCELLENT trial) [6]	722	721	2 (0.3%)	4 (0.6%)	NA	NA	NA	NA	4 (0.6%)	10 (1.4%)
Hu and Wang 2012 [10]	88	94	NA	NA	NA	NA	NA	NA	NA	NA
Kim et al. 2012 (RESET trial) [7]	1,059	1,058	2 (0.2%)	6 (0.6%)	NA	NA	NA	NA	5	10
Park et al. 2010 (REAL-LATE and ZEST-LATE) [8]	1,344	1,357	3 (0.2%)	1 (0.1%)	NA	NA	NA	NA	NA	NA
Valgimigli et al. 2012 (PRODIGY) [9]	983	987	6 (0.6%)	16 (1.6%)	NA	NA	4 (0.4%)	10 (1%)	15 (1.5%)	27 (2.7%)